Email this article Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol - PDF (Russian)
Copyright (c) 2024 «D. Rogachev NMRCPHOI»
This work is licensed under a Creative Commons Attribution 4.0 International License.